openPR Logo
Press release

Intra-Uterine Contraceptive Devices Market: Global Growth Factors Analysis, Top Companies Overview (Bayer AG, Teva Pharmaceuticals Industries Ltd., Mona Lisa N.V., DKT International, Egemen International, Melbea AG)

02-19-2019 03:42 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Intra-Uterine Contraceptive Devices Industry

Intra-Uterine Contraceptive Devices Industry

Intra-Uterine Contraceptive Devices Market report provides historical data along with future forecast and detailed analysis for Intra-Uterine Contraceptive Devices Market on a global and regional level. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The study encompasses a market attractiveness analysis, wherein each segment is benchmarked based on its market size, growth rate, and general attractiveness.

Some of the major market players in this market are:

Bayer AG, Teva Pharmaceutical Industries Ltd, Mona Lisa N.V., DKT INTERNATIONAL, OCON Medical Ltd, Pregna International Limited, MedWOW Global, SMB Corporation of India, Meril Life Sciences Pvt. Ltd, GYNEAS, Melbea Innovations, Meril Life Sciences Pvt. Ltd, Melbea AG, Medicines360, ALLERGAN, Agile therapeutics Inc. among others.

Get Free Sample Copy of this Report @

Market Segmentation: Global Intra-Uterine Contraceptive Devices Market

Product Type (Hormonal IUCD, Copper IUCD), End-User (Hospitals, Gynaecology Clinics, Community Healthcare), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Market Drivers: Global Intra-Uterine Contraceptive Devices Market

Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

Increased Rate of Unplanned Pregnancies :

Adolescents most commonly use contraceptive methods with relatively high typical use failure rates such as condoms, withdrawal, or oral contraceptive (OC) pills. Non-use, inconsistent use, and use of methods with high typical use failure rates are reflected in the high rate of unintended adolescent pregnancies in the U.S.

Rising Number of Initiatives Undertaken By the Private Firms :

The increasing number of initiatives taken by the U.S. government has helped to limit the rising number of unplanned pregnancies and abortions rate in the U.S. In addition, many U.S.-based private firms also contribute towards the solutions for pregnancy-related issues, which include maternal mortality, teenage pregnancies, growing number of abortions, and so on, by promoting the use of contraceptives, such as intrauterine contraceptive devices.

Favourable Insurance For IUCD’s :

The insurance policy is propelling the IUCD market towards growth. In Finland, national insurance covers acute but not preventive care, and contraceptives are usually paid by the patient. In Sweden, the copper IUCDs are available free of cost, whereas hormonal IUCDs are not. All FDA-approved contraceptives in the U.S. are covered by insurance.

Growing Awareness of Contraceptive :

The need to avoid unwanted pregnancies, especially among teenagers, is one of the major drivers for this market. It has also been observed that for over half of the users also identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain and acne, as reasons for use. This is also one of the factors contributing to the growth of the market in Europe.

Order a Copy of Global Intra-Uterine Contraceptive Devices Market Report @

The Global Intra-Uterine Contraceptive Devices Market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Bayer AG dominated the IUCD devices market accounting for a highest market share in 2016, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed among others holds 34.0% of the IUCDdelivery market in 2016.


Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science. The HealthCare segment offers a wide range of products under animal health, pharmaceuticals, consumer care, and medical care. The pharmaceutical business offers a wide range of products in the therapeutic area of oncology, haematology, and ophthalmology, and offers products for women’s health and cardiology therapeutic applications


Established in 1901 and headquartered in Petah Tikva, Israel, Teva is one of the leading global companies in IUCD devices market. The company is engaged in developing, producing, and marketing affordable generic drugs as well as innovative and specialty pharmaceutical ingredients. Teva operates through two business segments, namely generic medicine and specialty medicine. Teva’s specialty medicines business focuses on central nervous system (CNS), respiratory oncology, pain, and women’s health therapeutic areas as well as biologics.


Mona Lisa N.V. was founded in 1996, and is a subsidiary for EurimPharmaheadquarterd in Germany. Prior to 1996 the company was known as Homesteel-Achel which was an exclusive sub-manufacturer for Organon from 1980 to 1996. Mona Lisa specializes in manufacturing class II and III medical devices used in the field of gynecology. Mona Lisa N.V products are Copper-Intrauterine-Devices (IUD), Aspiration needles and Consultation services / sub-manufacturing services.

View Full Report @

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research
Tel: +1-888-387-2818

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intra-Uterine Contraceptive Devices Market: Global Growth Factors Analysis, Top Companies Overview (Bayer AG, Teva Pharmaceuticals Industries Ltd., Mona Lisa N.V., DKT International, Egemen International, Melbea AG) here

News-ID: 1600504 • Views: 642

More Releases from Data Bridge Market Research

E-Sports Market Competitive Outlook 2020: Leading Players Are Epic Games, Ninten …
New Jersey, United States: The eSports report is prepared by performing high-level market research analysis of key marketplace segments to identify opportunities, challenges, drivers, and market structures for the clients. With an efficient and comprehensive market research study, this eSports market research report provides the facts associated with any subject in the field of marketing. The market insights acquired through this market research report facilitates a more defined understanding of
Business Process Management (BPM) in Real Estate Market to see Major Growth by 2 …
Data Bridge Market Research recently introduced Global Business Process Management (BPM) in Real Estate Market research study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2026. The market Study is segmented by key regions which are accelerating the marketization. At present, the market is developing its presence and some of the key players in the study are IBM Corporation, Oracle, Red
Solid State Drive Market with Top Key Competitors | SAMSUNG; Intel Corporation; …
The latest 100+ page survey report on Solid State Drive Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges that
Service Robotics Market Innovative Technology Growth Applications, Analysis of K …
Data Bridge Market Research recently introduced Service Robotics Market research study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2026. The market Study is segmented by key regions which are accelerating the marketization. At present, the market is developing its presence and some of the key players in the study are Parrot Drones SAS; GeckoSystems Intl. Corp.; KUKA AG; DJI; Omron

All 5 Releases

More Releases for Contraceptive

Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Intrauterine Contraceptive Devices Market Future Opportunities 2025
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization.
Asia-Pacific Contraceptive Drugs Market Report 2017
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you. In this report, the Asia-Pacific Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request Sample Copy
Oral Contraceptive Pills Market: Regional & Competitive Analysis
According to TMR, the global oral contraceptive pills market is expected to be worth US$22.9 bn by 2023. On the basis of type, the position of combination oral contraceptive pill segment remains undisputed and is estimated to be worth US$18 bn by 2023. The segment is also identified as the fastest growing segment within the market. On the basis of category, the generic oral contraceptive pill segment will lead in
Intrauterine Contraceptive Devices (IUD) Market | Size | Analysis
Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long time period. IUD’S are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device which is made of flexible plastic along with a copper wire wrapped around its stem and is a reliable and safe method of sterilization for women. It is injected into the uterus, and their primary aim is to inhibit
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the